BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ramakrishnan P, Loh WM, Gopinath SCB, Bonam SR, Fareez IM, Mac Guad R, Sim MS, Wu YS. Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer. Acta Pharm Sin B 2020;10:399-413. [PMID: 32140388 DOI: 10.1016/j.apsb.2019.11.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Mohd Zaid NA, Sekar M, Bonam SR, Gan SH, Lum PT, Begum MY, Mat Rani NNI, Vaijanathappa J, Wu YS, Subramaniyan V, Fuloria NK, Fuloria S. Promising Natural Products in New Drug Design, Development, and Therapy for Skin Disorders: An Overview of Scientific Evidence and Understanding Their Mechanism of Action. Drug Des Devel Ther 2022;16:23-66. [PMID: 35027818 DOI: 10.2147/DDDT.S326332] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
2 Kalhori MR, Soleimani M, Arefian E, Alizadeh AM, Mansouri K, Echeverria J. The potential role of miR-1290 in cancer progression, diagnosis, prognosis, and treatment: An oncomiR or onco-suppressor microRNA? J Cell Biochem 2021. [PMID: 34897783 DOI: 10.1002/jcb.30191] [Reference Citation Analysis]
3 Bansod S, Saifi MA, Godugu C. Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model. Sci Rep 2021;11:12894. [PMID: 34145346 DOI: 10.1038/s41598-021-92461-z] [Reference Citation Analysis]
4 Lee HS, Kim SH, Kim BM, Safe S, Lee SO. Broussochalcone A Is a Novel Inhibitor of the Orphan Nuclear Receptor NR4A1 and Induces Apoptosis in Pancreatic Cancer Cells. Molecules 2021;26:2316. [PMID: 33923503 DOI: 10.3390/molecules26082316] [Reference Citation Analysis]
5 Luo G, Sun L, Li H, Chen J, He P, Zhao L, Tang W, Qiu H. The potent radioprotective agents: Novel nitronyl nitroxide radical spin-labeled resveratrol derivatives. Fitoterapia 2021;155:105053. [PMID: 34610355 DOI: 10.1016/j.fitote.2021.105053] [Reference Citation Analysis]
6 Ramli S, Sim MS, Guad RM, Gopinath SCB, Subramaniyan V, Fuloria S, Fuloria NK, Choy KW, Rana S, Wu YS. Long Noncoding RNA UCA1 in Gastrointestinal Cancers: Molecular Regulatory Roles and Patterns, Mechanisms, and Interactions. J Oncol 2021;2021:5519720. [PMID: 33936199 DOI: 10.1155/2021/5519720] [Reference Citation Analysis]
7 Muhamad Fadzil NS, Sekar M, Gan SH, Bonam SR, Wu YS, Vaijanathappa J, Ravi S, Lum PT, Dhadde SB. Chemistry, Pharmacology and Therapeutic Potential of Swertiamarin - A Promising Natural Lead for New Drug Discovery and Development. Drug Des Devel Ther 2021;15:2721-46. [PMID: 34188450 DOI: 10.2147/DDDT.S299753] [Reference Citation Analysis]
8 Deng T, Shen P, Li A, Zhang Z, Yang H, Deng X, Peng X, Hu Z, Tang Z, Liu J, Hou R, Liu Z, Fang W. CCDC65 as a new potential tumor suppressor induced by metformin inhibits activation of AKT1 via ubiquitination of ENO1 in gastric cancer. Theranostics 2021;11:8112-28. [PMID: 34335983 DOI: 10.7150/thno.54961] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Ren Y, Cui Q, Zhang J, Liu W, Xu M, Lv Y, Wu Z, Zhang Y, Wu R. Milk Fat Globule-EGF Factor 8 Alleviates Pancreatic Fibrosis by Inhibiting ER Stress-Induced Chaperone-Mediated Autophagy in Mice. Front Pharmacol 2021;12:707259. [PMID: 34421598 DOI: 10.3389/fphar.2021.707259] [Reference Citation Analysis]
10 Huang C, Iovanna J, Santofimia-Castaño P. Targeting Fibrosis: The Bridge That Connects Pancreatitis and Pancreatic Cancer. Int J Mol Sci 2021;22:4970. [PMID: 34067040 DOI: 10.3390/ijms22094970] [Reference Citation Analysis]
11 Chi Z, Chen L, Huang J, Jiang N, Zheng Q, Huang N, Yang W. A novel combination of percutaneous stenting with iodine-125 seed implantation and chemotherapy for the treatment of pancreatic head cancer with obstructive jaundice. Brachytherapy 2021;20:218-25. [PMID: 33158777 DOI: 10.1016/j.brachy.2020.09.009] [Reference Citation Analysis]
12 Ahmad RS, Eubank TD, Lukomski S, Boone BA. Immune Cell Modulation of the Extracellular Matrix Contributes to the Pathogenesis of Pancreatic Cancer. Biomolecules 2021;11:901. [PMID: 34204306 DOI: 10.3390/biom11060901] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Xia SH. Prospect and clinical value of oxymatrine in prevention and treatment of pancreatic fibrosis. Shijie Huaren Xiaohua Zazhi 2020; 28(17): 819-826 [DOI: 10.11569/wcjd.v28.i17.819] [Reference Citation Analysis]
14 Jia YC, Ding YX, Mei WT, Wang YT, Zheng Z, Qu YX, Liang K, Li J, Cao F, Li F. Extracellular vesicles and pancreatitis: mechanisms, status and perspectives. Int J Biol Sci 2021;17:549-61. [PMID: 33613112 DOI: 10.7150/ijbs.54858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jentzsch V, Davis JAA, Djamgoz MBA. Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management. Cancers (Basel) 2020;12:E3096. [PMID: 33114159 DOI: 10.3390/cancers12113096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Radoslavova S, Folcher A, Lefebvre T, Kondratska K, Guénin S, Dhennin-Duthille I, Gautier M, Prevarskaya N, Ouadid-Ahidouch H. Orai1 Channel Regulates Human-Activated Pancreatic Stellate Cell Proliferation and TGFβ1 Secretion through the AKT Signaling Pathway. Cancers (Basel) 2021;13:2395. [PMID: 34063470 DOI: 10.3390/cancers13102395] [Reference Citation Analysis]
17 Asgharian P, Tazehkand AP, Soofiyani SR, Hosseini K, Martorell M, Tarhriz V, Ahangari H, Cruz-Martins N, Sharifi-Rad J, Almarhoon ZM, Ydyrys A, Nurzhanyat A, Yessenbekova A, Cho WC. Quercetin Impact in Pancreatic Cancer: An Overview on Its Therapeutic Effects. Oxid Med Cell Longev 2021;2021:4393266. [PMID: 34777687 DOI: 10.1155/2021/4393266] [Reference Citation Analysis]
18 Cui L, Li C, Shang Y, Li D, Zhuo Y, Yang L, Cui N, Li Y, Zhang S. Chaihu Guizhi Ganjiang Decoction Ameliorates Pancreatic Fibrosis via JNK/mTOR Signaling Pathway. Front Pharmacol 2021;12:679557. [PMID: 34177589 DOI: 10.3389/fphar.2021.679557] [Reference Citation Analysis]
19 Gupta S, Tejavath KK. Nano Phytoceuticals: A Step Forward in Tracking Down Paths for Therapy Against Pancreatic Ductal Adenocarcinoma. J Clust Sci. [DOI: 10.1007/s10876-021-02213-2] [Reference Citation Analysis]
20 Koltai T, Reshkin SJ, Carvalho TMA, Cardone RA. Targeting the Stromal Pro-Tumoral Hyaluronan-CD44 Pathway in Pancreatic Cancer. Int J Mol Sci 2021;22:3953. [PMID: 33921242 DOI: 10.3390/ijms22083953] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Talib WH, Alsayed AR, Farhan F, Al Kury LT. Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets. Molecules 2020;25:E4282. [PMID: 32961987 DOI: 10.3390/molecules25184282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]